• Efficacy of asciminib in chronic phase chronic myeloid leukemia patients with T315I mutation

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Weekly Somatrogon versus Daily Somatropin in Children with Small for Gestational Age or Idiopathic Short Stature

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Greece Poland

  • Bempedoic acid in drug combination for patients with coronary artery disease without prior cardiovascular events

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy Spain

  • Open‑Label Extension Study of Avutometinib Alone or with Defactinib in Patients with Recurrent Low‑Grade Serous Ovarian Cancer

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Supplementary Oxygen Therapy for Patients with Fracture-Related Infection After Limb Debridement and Reconstruction Surgery: A Pilot Randomized Trial

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study of Enfortumab Vedotin and Pembrolizumab for Bladder Preservation in Patients with Muscle‑Invasive Bladder Cancer

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland Spain

  • Phase 2 Study of AGA2115 in Adults with Osteogenesis Imperfecta (COL1A1/COL1A2 Variants) Evaluating Bone Density

    Not yet recruiting

    2 1
    Investigated diseases:
    Denmark France The Netherlands

  • A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis

    Not yet recruiting

    3 1
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Long‑Term Safety Study of ADX‑324 in Participants with Hereditary Angioedema (Phase 3 Extension)

    Not yet recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Czechia France +5

  • Feasibility and Safety of PEX010 Psilocybin Capsules (5 mg and 25 mg) in Military Veterans with Posttraumatic Stress Disorder

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

powered by